Chun H., Leyland-Jones B., Cheson B.: Fludarabine phosphate: A synthetic purine antimetabolite with significant activity against lymphoid malignancies. J Clin Oncol9:175-188, 1991
3.
Plunkett W., Huang P., Gandhi V.: Metabolism and action of fludarabine phosphate. Semin Oncol173-17, 1990
4.
Grever M., Leiby J., Kraut E., et al. A comprehensive phase I and II clinical investigation of fludarabine phosphate. Semin Oncol17:39-48, 1990
5.
Keating M.: Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Semin Oncol17:49-62, 1990
6.
Von Hoff D.: Phase I clinical trials with fludarabine phosphate. Semin Oncol1733-38, 1990
7.
Malspeis L., Grever M., Staubus A., et al: Pharmacokinetics of 2-F-ara-A (9-β-D-Arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate. Semin Oncol17:18-32, 1990
8.
Cheson B.: Issues in the future development of fludarabine phosphate. Semin Oncol17:71-78, 1990 (Suppl 8)
9.
Weiss G., Phillips J., Schwarz R., et al: Phase I and pharmacokinetic study of intraperitoneal fludarabine phosphate for peritoneal cancer. Proc Am Soc Clin Oncol4:30, 1985
